These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 34790627)
1. Cardiac Sodium Channel Blockade Due to Antiepileptic Drug Combination. Maadarani O; Bitar Z; Ashkanani A; Elzoueiry M; Elhabibi M; Gohar M; Almuwaizri M; Shoeb S; Alsaddah J Eur J Case Rep Intern Med; 2021; 8(10):002839. PubMed ID: 34790627 [TBL] [Abstract][Full Text] [Related]
2. A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs. Sake JK; Hebert D; Isojärvi J; Doty P; De Backer M; Davies K; Eggert-Formella A; Zackheim J CNS Drugs; 2010 Dec; 24(12):1055-68. PubMed ID: 21090839 [TBL] [Abstract][Full Text] [Related]
3. [The efficacy of lacosamide in relation to antiepileptic drug history. Clinical experiences in adult partial epilepsy]. Barcs Gábor ; Szűcs A; Horváth A; Kamondi A Ideggyogy Sz; 2015 Jan; 68(1-2):23-9. PubMed ID: 25842913 [TBL] [Abstract][Full Text] [Related]
4. Cardiac sodium channel blockade after an intentional ingestion of lacosamide, cyclobenzaprine, and levetiracetam: Case report. Chua-Tuan JL; Cao D; Iwanicki JL; Hoyte CO Clin Toxicol (Phila); 2015 Jul; 53(6):565-8. PubMed ID: 25951877 [TBL] [Abstract][Full Text] [Related]
5. Lacosamide for SCN2A-related intractable neonatal and infantile seizures. Flor-Hirsch H; Heyman E; Livneh A; Reish O; Watemberg N; Litmanovits I; Ben Sason Lilli A; Lev D; Lerman Sagie T; Bassan H Epileptic Disord; 2018 Oct; 20(5):440-446. PubMed ID: 30361185 [TBL] [Abstract][Full Text] [Related]
6. Lacosamide induced Brugada I morphology in the setting of septicemia: A case report. Goodnough R; Badea A; Geier C; Lynch KL; LeSaint KT Medicine (Baltimore); 2021 May; 100(18):e25577. PubMed ID: 33950934 [TBL] [Abstract][Full Text] [Related]
7. Current understanding of the mechanism of action of the antiepileptic drug lacosamide. Rogawski MA; Tofighy A; White HS; Matagne A; Wolff C Epilepsy Res; 2015 Feb; 110():189-205. PubMed ID: 25616473 [TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of epilepsy: newly approved and developmental agents. Stephen LJ; Brodie MJ CNS Drugs; 2011 Feb; 25(2):89-107. PubMed ID: 21254787 [TBL] [Abstract][Full Text] [Related]
9. Review of therapeutic options for adjuvant treatment of focal seizures in epilepsy: focus on lacosamide. Becerra JL; Ojeda J; Corredera E; Ruiz Giménez J CNS Drugs; 2011 Dec; 25 Suppl 1():3-16. PubMed ID: 22141347 [TBL] [Abstract][Full Text] [Related]
10. Lacosamide: A Review in Focal-Onset Seizures in Patients with Epilepsy. Hoy SM CNS Drugs; 2018 May; 32(5):473-484. PubMed ID: 29785508 [TBL] [Abstract][Full Text] [Related]
11. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. Nolan SJ; Marson AG; Weston J; Tudur Smith C Cochrane Database Syst Rev; 2015 Aug; (8):CD001911. PubMed ID: 26275105 [TBL] [Abstract][Full Text] [Related]
12. Lacosamide effectiveness and tolerability in patients with drug-resistant epilepsy and severe disability under polytherapy: Therapy optimization as emerging from an observational study. Pozzi M; Zanotta N; Epifanio R; Baldelli S; Cattaneo D; Clementi E; Zucca C Epilepsy Behav; 2022 Mar; 128():108598. PubMed ID: 35151192 [TBL] [Abstract][Full Text] [Related]
13. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study. Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971 [TBL] [Abstract][Full Text] [Related]
14. Cardiac safety of lacosamide: the non-clinical perspective. Delaunois A; Colomar A; Depelchin BO; Cornet M Acta Neurol Scand; 2015 Nov; 132(5):337-45. PubMed ID: 25903789 [TBL] [Abstract][Full Text] [Related]
15. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group. Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in adjunctive therapy for epilepsy: focus on sodium channel blockers as third-generation antiepileptic drugs. Vohora D; Saraogi P; Yazdani MA; Bhowmik M; Khanam R; Pillai KK Drugs Today (Barc); 2010 Apr; 46(4):265-77. PubMed ID: 20502724 [TBL] [Abstract][Full Text] [Related]
17. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review. Nolan SJ; Marson AG; Weston J; Tudur Smith C Cochrane Database Syst Rev; 2015 Jul; (7):CD001904. PubMed ID: 26204241 [TBL] [Abstract][Full Text] [Related]
18. Adjunctive lacosamide in clinical practice: sodium blockade with a difference? Stephen LJ; Kelly K; Parker P; Brodie MJ Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421 [TBL] [Abstract][Full Text] [Related]
19. Lacosamide in patients with epilepsy of cerebrovascular etiology. Rosenow F; Brandt C; Bozorg A; Dimova S; Steiniger-Brach B; Zhang Y; Ferrò B; Holmes GL; Kälviäinen R Acta Neurol Scand; 2020 Jun; 141(6):473-482. PubMed ID: 32068241 [TBL] [Abstract][Full Text] [Related]
20. [Lacosamide associated with high-degree block in a patient with trigeminal neuralgia]. Marin-Gracia M; Cantero-Lozano D; Garces-Anton E; Lopez-Bravo A; Garrido-Fernandez A; Navarro-Perez MP; Santos-Lasaosa S; Garces-Redondo M Rev Neurol; 2018 Mar; 66(6):189-192. PubMed ID: 29537058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]